Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic vasculitis

M J Dillon1

  • 1Hospital for Sick Children, London, UK.

Clinical and Experimental Rheumatology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Systemic vasculitides are rare childhood disorders. Advances in diagnosis and treatment improve outcomes, but a deeper understanding of conditions like polyarteritis and Kawasaki disease is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-based optical assays in the food safety field.

Trends in analytical chemistry : TRAC·2020
Same author

Cardiovascular status after Kawasaki disease in the UK.

Heart (British Cardiac Society)·2015
Same author

[Management of high blood pressure in children and adolescents: Recommendations of the European Society of hypertension].

Anales de pediatria (Barcelona, Spain : 2003)·2010
Same author

Hypertension in children.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
Same author

T cell activation profiles in Kawasaki syndrome.

Clinical and experimental immunology·2007
Same author

Henoch-Schönlein purpura: recent advances.

Clinical and experimental rheumatology·2007
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Area of Science:

  • Pediatrics
  • Rheumatology
  • Immunology

Background:

  • Systemic vasculitides are uncommon yet significant pediatric diseases.
  • Henoch-Schönlein purpura is the most frequent type, followed by Kawasaki disease.
  • Polyarteritis and Wegener's granulomatosis are less common but severe, with high morbidity and mortality.

Purpose of the Study:

  • To review the current understanding and management of childhood systemic vasculitides.
  • To highlight the importance of accurate diagnosis and improved therapeutic approaches.
  • To emphasize the need for further research into the underlying mechanisms of these diseases.

Main Methods:

  • Review of existing literature on childhood vasculitides.
  • Analysis of diagnostic and therapeutic advancements.

Related Experiment Videos

  • Discussion of specific conditions including polyarteritis, Kawasaki disease, and Wegener's granulomatosis.

    • Main Results:

    • Newer diagnostic tools and treatments have enhanced patient outcomes.
    • Despite progress, significant challenges remain in managing severe forms of vasculitis.
    • Understanding the role of antineutrophil cytoplasmic antibodies (ANCA) is crucial for certain vasculitides.

    Conclusions:

    • Continued research into the pathophysiology of vasculitides is essential for further therapeutic progress.
    • Accurate and timely diagnosis remains critical for improving the prognosis of affected children.
    • A comprehensive understanding of polyarteritis, Kawasaki disease, Wegener's granulomatosis, and ANCA is vital for pediatric rheumatology.